Structure and function of therapeutic antibodies approved by the US FDA in 2023.

Antib Ther · 2024 · PMC11011201 · PMID 38617189

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

fairly significantno p-value reported

ADA response was fairly significant, with nearly half (45%) of all patients administered with the drug experiencing at least some ADA response.

also in 167 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.